Daily FNArena News - Australia

The prospects for Medibank Private in the medium term rest on whether it can stabilise market share and retain healthy margins.

A summary of the previous session’s corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

Cash is flowing at Qantas and the company rounded off a robust FY17 result with a reinstated buy-back. Is there more to come?

A summary of the previous session’s corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

A summary of the previous session’s corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

Chicken producer Ingham’s is facing higher feed and electricity costs but strong volume growth evident in FY17 is expected to help the well-placed business ride out the headwinds.

A summary of the previous session’s corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

A summary of the previous session’s corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

Brokers brushed aside the FY17 results for Fortescue Metals, enthusing over the surprise increase in the second half dividend and the new dividend pay-out policy.

Primary Health Care has completed a year of transition but there is more to come and most brokers are taking a back seat, awaiting further clarity.